In vitro sub-hemolytic effects of butoxyacetic acid on human and rat erythrocytes

Toxicological Sciences

Volumn 69, Issue 1, 2002, Pages 258-264

  Udden, Mark M ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

2 butoxyethanol; Butoxyacetic acid; Ethylene glycol monobutyl ether; Glycol ethers; Hemolysis; Human erythrocytes; Rat erythrocytes

Indexed keywords

2 BUTOXYETHANOL; ACETIC ACID DERIVATIVE; BUTOXYACETIC ACID; SODIUM; UNCLASSIFIED DRUG;

ADULT; ANIMAL CELL; ARTICLE; BLOOD SAMPLING; CELL DENSITY; CELL SWELLING; CHILD; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ERYTHROCYTE; ERYTHROCYTE DEFORMABILITY; ERYTHROCYTE FRAGILITY; ERYTHROCYTE VOLUME; EXPOSURE; HEMOLYSIS; HUMAN; HUMAN CELL; IN VITRO STUDY; NONHUMAN; RAT; SODIUM CELL LEVEL; SPHEROCYTOSIS;

ANIMALS; CATIONS; CELL SIZE; DENSITOMETRY; ERYTHROCYTES; FILTRATION; GLYCOLATES; HEMOLYSIS; HUMANS; MICROSCOPY, PHASE-CONTRAST; OSMOTIC FRAGILITY; RATS;

ANIMALIA;

EID: 0036738716     PISSN: 10966080     EISSN: None     Source Type: Journal    
DOI: 10.1093/toxsci/69.1.258     Document Type: Article

References (16)

1. Bartnik, F. G., Reddy, A. K., Klecak, G., Zimmermann, V., Hostynek, J. J., and Kunstler, K. (1987). Percutaneous absorption, metabolism, and hemolytic activity of n-butoxyethanol. Fundam. Appl. Toxicol. 8, 59-70.
2. Beutler, E. (1995). Osmotic fragility. In Williams Hematology (E. Beutler, M. A. Lichtman, B. S. Coller, and T. J. Kipps, Eds.), pp. L46-47. McGraw-Hill, New York.
3. Carpenter, C. P., Pozzani, U. C., Weil, C. S., Nair, J. H., Keck, G. A., and Smyth, H. F. (1956). The toxicity of butyl cellosolve solvent. Arch. Ind. Health 14, 114-131.
4. Chien, S. (1977). Principles and techniques for assessing erythrocyte deformability. Blood Cells 3, 71-99.
5. Corely, R. A., Bormett, G. A., and Ghanayem, B. I. (1994). Physiologically based pharmacokinetics of 2-butoxyethanol and its major metabolite, 2-butoxyacetic acid, in rats and humans. Toxicol. Appl. Pharmacol. 129, 61-79.
6. Danon, D., and Marikovsky, Y. (1964). Determination of density distribution of red cell population. J. Lab. Clin. Med. 64, 668-674.
7. Ghanayem, B. I. (1989). Metabolic and cellular basis of 2-butoxyethanol-induced hemolytic anemia in rats and assessment of human risk in vitro. Biochem. Pharmacol. 38, 1679-1684.
8. Ghanayem, B. I., Burka, L. T., and Matthews, H. B. (1987). Metabolic basis of ethylene glycol monobutyl ether (2-butoxyethanol) toxicity: Role of alcohol and aldehyde dehydrogenases. J. Pharmacol. Exp. Ther. 242, 222-231.
9. Ghanayem, B. I., and Sullivan, C. A. (1993). Assessment of the haemolytic activity of 2-butoxyethanol and its major metabolic, butoxyacetic acid, in various mammals including humans. Hum. Exp. Toxicol. 12, 305-311.
10. Ghanayem, B. I., Ward, S. M., Blair, P. C., and Mathews, H. B. (1990). Comparison of the hematologic effects of 2-butoxyethanol using two types of hematology analyzers. Toxicol. Applied. Pharmacol. 106, 341-345.
11. Gingell, R., Boatman, R. J., and Lewis, S. (1998). Acute toxicity of ethylene glycol mono-n-butyl ether in the guinea pig. Food Chem. Toxicol. 36, 825-829.
12. Mohandas, N., Clark, M. R., Jacobs, M. S., and Shohet, S. B. (1980). Analysis of factors regulating erythrocyte deformability. J. Clin. Invest. 66, 563-573.
13. O'Rear, E. A., McIntire, L. V., Shah, B. O., and Lynch, E. C. (1979). Use of a rheological technique to evaluate erythrocyte membrane alterations. J. Rheol. 23, 721-733.
14. Udden, M. M. (1994). Hemolysis and deformability of erythrocytes exposed to butoxyacetic acid, a metabolite of 2-butoxyethanol: II. Resistance in red blood cells from humans with potential susceptibility. J. Appl. Toxicol. 14, 97-102.
15. Udden, M. M. (2000). Rat erythrocyte morphological changes after gavage dosing with 2-butoxyethanol: A comparison to the in vitro effects of butoxyacetic acid on rat and human erythrocytes. J. Appl. Toxicol. 20, 381-387.
16. Udden, M. M., and Patton, C. S. (1994). Hemolysis and deformability of erythrocytes exposed to butoxyacetic acid, a metabolite of 2-butoxyethanol: I. Sensitivity in rats and resistance in normal humans. J. Appl. Toxicol. 14, 91-96.